Tmunity Therapeutics

Biotech

Gilead's Kite swoops in to buy CAR-T focused Tmunity

Kite Pharma is buying Carl June-founded Tmunity for an undisclosed sum, accessing the University of Pennsylvania's research apparatus in the process.
Max Bayer Dec 20, 2022 8:00am

Biopharma charts progress in translating CAR-T to solid cancers

Dec 15, 2021 3:00am

Founder-led biotech makes space for ideas—and diverse leaders

Nov 23, 2021 7:00am

Tmunity stops solid tumor CAR-T trial after 2 patients die

Jun 3, 2021 8:40am

Tmunity expands Penn pact, picking up another CAR-T program

Feb 9, 2021 10:10am

Biopharma targets cancer with next-gen cell therapies

Sep 14, 2020 4:15pm